LEADER 03704oam  2200613Ia 450 
001 9910781057303321
005 20231127162322.0
010   $a1-282-45614-8
010   $a9786612456145
010   $a92-4-068424-7
035   $a(CKB)2550000000005665
035   $a(EBL)476161
035   $a(OCoLC)609852935
035   $a(SSID)ssj0000367559
035   $a(PQKBManifestationID)11265667
035   $a(PQKBTitleCode)TC0000367559
035   $a(PQKBWorkID)10311380
035   $a(PQKB)10081559
035   $a(MiAaPQ)EBC476161
035   $a(Au-PeEL)EBL476161
035   $a(CaPaEBR)ebr10363981
035   $a(CaONFJC)MIL245614
035   $a(EXLCZ)992550000000005665
100   $a20090523d2009      uf             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aWHO model formulary 2008 /$f[edited by Mark C. Stuart, Maria Kouimtzi, Suzanne R. Hill]
210  1$aGeneva :$cWorld Health Organization,$d2009.
215   $a1 online resource (645 pages)
300   $a"Based on the 15th Model list of essential medicines 2007."
300   $aIncludes index.
311 0 $a92-4-154765-0 
327   $aWHO MODEL FORMULARY 2008; Title Page; Contents; Abbreviations; Introduction; Changes to the WHO Model List of Essential; General advice to prescribers; 1. Anaesthetics; 2. Analgesics, antipyretics, non-steroidal anti-inflammatory; 3. Antiallergics and medicines used in anaphylaxis; 4. Antidotes and other substances used in poisonings; 5. Anticonvulsants/antiepileptics; 6. Anti-infective medicines; 7. Antimigraine medicines; 8. Antineoplastic, immunosuppressives and medicines used; 9. Antiparkinsonism medicines; 10. Medicines affecting the blood; 11. Blood products and plasma substitutes
327   $a12. Cardiovascular medicines; 13. Dermatological medicines (topical); 14. Diagnostic agents; 15. Disinfectants and antiseptics; 16. Diuretics; 17. Gastrointestinal medicines; 18. Hormones, other endocrine medicines and contraceptives; 19. Immunologicals; 20. Muscle relaxants (peripherally-acting) and cholinesterase; 21. Ophthalmological preparations; 22. Oxytocics and antioxytocics; 23. Peritoneal dialysis solution; 24. Psychotherapeutic medicines; 25. Medicines acting on the respiratory tract; 26. Solutions correcting water, electrolyte and acid-base; 27. Vitamins and minerals; Appendix 1: Interactions; Appendix 2: Pregnancy; Appendix 3: Breastfeeding; Appendix 4: Renal impairment; Appendix 5: Hepatic impairment; Index
330   $aSince its first publication in 2002, the WHO Model Formulary has become an indispensable source of independent information on essential medicines for pharmaceutical policy-makers and prescribers worldwide. The Model Formulary is the authoritative guide on how to make effective use of the medicines on the WHO Model List of Essential Medicines, so improving patient safety, and limiting unnecessary medical spending. For each medicine the Model Formulary provides information on use, dosage, adverse effects, contraindications and warnings, supplemented by guidance on selecting the right medicine fo
606   $aMedicine$vFormulae, receipts, prescriptions
606   $aDrugs$xPrescribing
615  0$aMedicine
615  0$aDrugs$xPrescribing.
676   $a615.13
701   $aStuart$b Mark C$01465135
701   $aKouimtzi$b Maria$01465136
701   $aHill$b Suzanne$0877980
712 02$aWorld Health Organization.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910781057303321
996   $aWHO model formulary 2008$93675000
997   $aUNINA